Shares of Max Healthcare Institute Limited fell 1.8% to Rs 1,152.30 in Friday's session, with high trading volume, as the stock recorded one of its sharpest declines. The stock is among the top losers on the Nifty Midcap 150 index.
Max Healthcare Institute is part of the Nifty Midcap 150 index.
Consolidated Quarterly Results:
The company's consolidated quarterly revenue has shown consistent growth over the past year. The revenue for the quarter-ending June 2025 stood at Rs 2,027.57 Crore, marking an increase from Rs 1,909.74 Crore in March 2025. Net profit for the same quarter was reported at Rs 307.97 Crore. In comparison, the revenue for June 2024 was Rs 1,542.95 Crore, with a net profit of Rs 236.27 Crore.
Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|
Revenue | Rs 1,542.95 Crore | Rs 1,707.46 Crore | Rs 1,868.31 Crore | Rs 1,909.74 Crore | Rs 2,027.57 Crore |
Net Profit | Rs 236.27 Crore | Rs 281.81 Crore | Rs 238.80 Crore | Rs 319.00 Crore | Rs 307.97 Crore |
EPS | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
Consolidated Yearly Results:
The annual revenue has also demonstrated a strong upward trend, with the revenue for the year-ending March 2025 reaching Rs 7,028.46 Crore, a substantial increase from Rs 5,406.02 Crore in March 2024. The net profit for the year-ending March 2025 was Rs 1,075.88 Crore, slightly higher than the Rs 1,057.64 Crore reported in March 2024.
Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Revenue | Rs 2,504.67 Crore | Rs 3,931.46 Crore | Rs 4,562.60 Crore | Rs 5,406.02 Crore | Rs 7,028.46 Crore |
Net Profit | Rs -114.50 Crore | Rs 605.05 Crore | Rs 1,103.51 Crore | Rs 1,057.64 Crore | Rs 1,075.88 Crore |
EPS | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 |
BVPS | 58.37 | 64.79 | 76.31 | 86.51 | 96.50 |
ROE | -2.43 | 9.63 | 14.89 | 12.57 | 11.46 |
Debt to Equity | 0.16 | 0.12 | 0.08 | 0.14 | 0.27 |
Consolidated Yearly Income Statement:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Sales | Rs 7,028 Crore | Rs 5,406 Crore | Rs 4,562 Crore | Rs 3,931 Crore | Rs 2,504 Crore |
Other Income | Rs 155 Crore | Rs 178 Crore | Rs 139 Crore | Rs 127 Crore | Rs 114 Crore |
Total Income | Rs 7,184 Crore | Rs 5,584 Crore | Rs 4,701 Crore | Rs 4,058 Crore | Rs 2,619 Crore |
Total Expenditure | Rs 5,612 Crore | Rs 4,158 Crore | Rs 3,554 Crore | Rs 3,219 Crore | Rs 2,508 Crore |
EBIT | Rs 1,571 Crore | Rs 1,425 Crore | Rs 1,147 Crore | Rs 839 Crore | Rs 110 Crore |
Interest | Rs 165 Crore | Rs 59 Crore | Rs 83 Crore | Rs 100 Crore | Rs 179 Crore |
Tax | Rs 330 Crore | Rs 307 Crore | Rs -39 Crore | Rs 133 Crore | Rs 45 Crore |
Net Profit | Rs 1,075 Crore | Rs 1,057 Crore | Rs 1,103 Crore | Rs 605 Crore | Rs -114 Crore |
Consolidated Quarterly Income Statement:
Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
---|---|---|---|---|---|
Sales | Rs 2,027 Crore | Rs 1,909 Crore | Rs 1,868 Crore | Rs 1,707 Crore | Rs 1,542 Crore |
Other Income | Rs 36 Crore | Rs 46 Crore | Rs 33 Crore | Rs 40 Crore | Rs 34 Crore |
Total Income | Rs 2,064 Crore | Rs 1,956 Crore | Rs 1,901 Crore | Rs 1,748 Crore | Rs 1,577 Crore |
Total Expenditure | Rs 1,608 Crore | Rs 1,498 Crore | Rs 1,540 Crore | Rs 1,341 Crore | Rs 1,232 Crore |
EBIT | Rs 455 Crore | Rs 457 Crore | Rs 361 Crore | Rs 407 Crore | Rs 345 Crore |
Interest | Rs 54 Crore | Rs 55 Crore | Rs 52 Crore | Rs 33 Crore | Rs 23 Crore |
Tax | Rs 92 Crore | Rs 83 Crore | Rs 70 Crore | Rs 91 Crore | Rs 85 Crore |
Net Profit | Rs 307 Crore | Rs 319 Crore | Rs 238 Crore | Rs 281 Crore | Rs 236 Crore |
Consolidated Balance Sheet:
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
---|---|---|---|---|---|
Share Capital | Rs 972 Crore | Rs 971 Crore | Rs 970 Crore | Rs 969 Crore | Rs 965 Crore |
Reserves & Surplus | Rs 8,408 Crore | Rs 7,368 Crore | Rs 6,397 Crore | Rs 5,290 Crore | Rs 4,646 Crore |
Current Liabilities | Rs 1,813 Crore | Rs 1,248 Crore | Rs 1,045 Crore | Rs 757 Crore | Rs 776 Crore |
Other Liabilities | Rs 4,019 Crore | Rs 2,410 Crore | Rs 1,688 Crore | Rs 2,171 Crore | Rs 2,155 Crore |
Total Liabilities | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Fixed Assets | Rs 8,922 Crore | Rs 6,384 Crore | Rs 4,836 Crore | Rs 4,714 Crore | Rs 4,108 Crore |
Current Assets | Rs 1,592 Crore | Rs 1,706 Crore | Rs 1,943 Crore | Rs 1,000 Crore | Rs 1,124 Crore |
Other Assets | Rs 4,699 Crore | Rs 3,909 Crore | Rs 3,322 Crore | Rs 3,474 Crore | Rs 3,311 Crore |
Total Assets | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
Contingent Liabilities | Rs 1,374 Crore | Rs 1,169 Crore | Rs 326 Crore | Rs 515 Crore | Rs 388 Crore |
Consolidated Financial Ratios:
Ratio | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|
Basic EPS (Rs.) | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 |
Diluted Eps (Rs.) | -1.59 | 6.24 | 11.36 | 10.84 | 11.01 |
Book Value [Excl. Reval Reserve]/Share (Rs.) | 58.37 | 64.79 | 76.31 | 86.51 | 96.50 |
Dividend/Share (Rs.) | 0.00 | 0.00 | 0.00 | 1.50 | 1.50 |
Face Value | 10 | 10 | 10 | 10 | 10 |
Gross Profit Margin (%) | 20.70 | 27.21 | 30.24 | 30.89 | 28.51 |
Operating Margin (%) | 13.75 | 21.58 | 25.15 | 26.36 | 23.40 |
Net Profit Margin (%) | -4.57 | 15.38 | 24.18 | 19.56 | 15.30 |
Return on Networth / Equity (%) | -2.43 | 9.63 | 14.89 | 12.57 | 11.46 |
ROCE (%) | 4.43 | 10.06 | 12.67 | 13.25 | 12.27 |
Return On Assets (%) | -1.60 | 6.58 | 10.92 | 8.81 | 7.07 |
Current Ratio (X) | 1.45 | 1.32 | 1.86 | 1.37 | 0.88 |
Quick Ratio (X) | 1.38 | 1.24 | 1.79 | 1.30 | 0.82 |
Debt to Equity (x) | 0.16 | 0.12 | 0.08 | 0.14 | 0.27 |
Interest Coverage Ratios (X) | 1.92 | 10.61 | 16.45 | 27.89 | 12.15 |
Asset Turnover Ratio (%) | 29.31 | 0.22 | 0.22 | 0.49 | 0.52 |
Inventory Turnover Ratio (X) | 46.56 | 0.00 | 0.00 | 0.00 | 74.28 |
3 Yr CAGR Sales (%) | 4,904.67 | 6,170.14 | 107.56 | 46.91 | 33.71 |
3 Yr CAGR Net Profit (%) | 970.05 | 2,359.78 | 824.54 | 203.92 | 33.35 |
P/E (x) | -129.40 | 55.62 | 38.76 | 75.29 | 99.09 |
P/B (x) | 3.53 | 5.35 | 5.78 | 9.48 | 11.37 |
EV/EBITDA (x) | 38.85 | 31.65 | 30.38 | 47.77 | 54.09 |
P/S (x) | 7.95 | 8.56 | 9.38 | 14.75 | 15.17 |
The company had announced a final dividend of Rs 1.50 per share (15%) with effective date as July 04, 2025.
With the stock's last traded price at Rs 1,152.30, Max Healthcare Institute saw a decline of 1.8%.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.